NODELMAN OLEG
SEC CIK 1454385 · EDGAR
BoughtSold
Most active insiders at AKTS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NODELMAN OLEG | Dir | $40.00M | — |
| 2 | MPM ONCOLOGY INNOVATIONS FUND LP | 10% | $20.03M | — |
| 3 | GADICKE ANSBERT | 10% | $20.03M | — |
| 4 | VIDA VENTURES II-A, LLC | 10% | $15.03M | — |
| 5 | Kim Helen Susan | Dir, 10% | $15.03M | — |
| 6 | Foley Todd | Dir, 10% | $4.19M | — |
| 7 | Czibere Akos | Chief Medical Off | — | $1.65M |
| 8 | Ron-Bigger Shulamit | COO | — | $1.39M |
| 9 | Herrmann Ken | Dir | — | $196.5K |
| 10 | Segal Lloyd Mitchell | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-01-12 | 2026-01-12 | AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Dir | P - Purchase | $18.00 | +2.22M | 347.3K | New | +$40.00M |
| DMI | 2026-01-12 | 2026-01-12 | AKTS | Aktis Oncology, Inc. | NODELMAN OLEG | Dir | C - Cnv Deriv | — | +2.60M | 2.27M | New | — |
| DI | 2025-06-27 | 2025-06-26 | ZYME | Zymeworks Inc. | NODELMAN OLEG | Dir, 10% | X - OptEx | $0.00 | +5.09M | 22.97M | +28% | $0 |
| DI | 2025-06-27 | 2025-06-26 | ZYME | Zymeworks Inc. | NODELMAN OLEG | Dir, 10% | F - Tax | $12.71 | -41 | 22.97M | -0.0% | -$521.11 |
| MI | 2025-04-07 | 2025-04-03+ | ZYME | Zymeworks Inc. | NODELMAN OLEG | Dir, 10% | P - Purchase | $11.43 | +317.2K | 17.70M | +2% | +$3.62M |
| MI | 2025-03-13 | 2025-03-11+ | ZYME | Zymeworks Inc. | NODELMAN OLEG | Dir, 10% | P - Purchase | $12.12 | +1.08M | 16.04M | +7% | +$13.12M |
| MI | 2023-09-21 | 2023-02-19+ | NUVB | Nuvation Bio Inc. | NODELMAN OLEG | Dir | P - Purchase | $1.26 | +5.31M | 12.50M | +74% | +$6.71M |
Purchase Sale Sale after option exercise All abbreviations